![]() |
市場調查報告書
商品編碼
1900735
神經科設備市場規模、佔有率和成長分析(按產品類型、最終用戶和地區分類)-2026-2033年產業預測Neurology Devices Market Size, Share, and Growth Analysis, By Product Type (Neurostimulation, Interventional Neurology), By End User (Hospitals, Ambulatory Surgery Centers), By Region - Industry Forecast 2026-2033 |
||||||
預計到 2024 年,全球神經科設備市場規模將達到 170.4 億美元,到 2025 年將達到 184.2 億美元,到 2033 年將達到 343.5 億美元,預測期(2026-2033 年)的複合年成長率為 8.1%。
全球神經系統疾病器材市場預計將迎來顯著成長,這主要得益於神經系統疾病盛行率的上升、私部門投資的增加以及神經治療研發的進步。阿茲海默症、帕金森氏症和癲癇等疾病的發病率不斷攀升,尤其是在老齡化人口中,這推動了對創新診斷和治療器械的需求。此外,神經系統疾病和心血管疾病的快速成長、公眾意識的提高以及微創手術的趨勢,也促進了對神經血管器械的需求。然而,高成本、監管嚴格、發展中地區准入受限以及併發症風險等挑戰,可能會阻礙市場的長期成長和普及。
全球神經病學器材市場促進因素
不良生活方式和不健康習慣導致的神經血管疾病日益增多,顯著推動了對神經血管器械的需求。中風和腦動脈瘤等疾病的發生率不斷上升,進一步刺激了市場需求。此外,全球人口老化也是造成此趨勢的重要因素,因為老年人更容易患上阿茲海默症、帕金森氏症和失智症神經系統疾病和神經退化性疾病。這種人口結構變化在北美、歐洲和亞洲部分地區尤為顯著,醫療保健系統面臨越來越大的挑戰,需要提供有效的診斷和神經系統服務,以滿足這些弱勢群體日益成長的需求。
限制全球神經科設備市場的因素
由於先進的神經血管裝置運用了創新醫療技術,其高成本對全球神經科器械市場構成了重大挑戰。已開發國家或許能夠負擔這些費用,但發展中國家的醫療機構往往面臨預算限制,阻礙了他們取得這些裝置。此外,缺乏操作這些先進技術和解讀結果的專業培訓,也為有效的神經科治療帶來了額外的障礙。許多醫療資源匱乏地區的醫療機構缺乏整合這些創新技術所需的資源,這凸顯了迫切需要經濟有效的解決方案和加強培訓舉措,以提高醫療服務的可及性和改善患者預後。
全球神經病學設備市場趨勢
全球神經科設備市場正經歷顯著的發展趨勢,而這主要得益於神經刺激技術的進步。旨在向特定腦區和神經傳遞電脈衝的設備正在改變慢性疼痛、癲癇、帕金森氏症和失智症疾病的治療格局。諸如深部腦部刺激(DBS)和脊髓刺激設備(SCS)等創新技術正日益受到關注,因為它們提供了一種微創替代方案,既能緩解症狀,又能提高患者的生活品質。對具有更高精度、更強連接性和更長電池續航時間的神經刺激設備的需求不斷成長,反映出患者和醫療專業人員對先進治療方案的日益青睞。
Global Neurology Devices Market size was valued at USD 17.04 Billion in 2024 and is poised to grow from USD 18.42 Billion in 2025 to USD 34.35 Billion by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).
The global neurology devices market is poised for significant growth, driven by the rising prevalence of neurological disorders, increasing investments from private sectors, and advancements in neurotherapy research and development. The escalating need for innovative diagnostic and therapeutic devices stems from the growing incidence of conditions such as Alzheimer's, Parkinson's, and epilepsy, particularly among the aging population, which faces a higher risk of such ailments. Additionally, the demand for neurovascular devices is buoyed by a surge in neurological and cardiovascular conditions, heightened awareness, and the trend towards minimally invasive procedures. However, challenges like the high cost of devices, stringent regulations, limited access in developing regions, and the risk of complications may hinder long-term market growth and accessibility.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurology Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Neurology Devices Market Segments Analysis
Global Neurology Devices Market is segmented by Product Type, End User and region. Based on Product Type, the market is segmented into Neurostimulation, Interventional Neurology, CSF Management Devices and Neurosurgery Devices. Based on End User, the market is segmented into Hospitals, Ambulatory Surgery Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Neurology Devices Market
The rise in neurovascular diseases, attributed to poor lifestyle choices and unhealthy habits, has led to a marked increase in the need for neurovascular devices. Conditions such as strokes and cerebral aneurysms are becoming more prevalent, driving demand in the market. Additionally, the global aging population is contributing significantly to this trend, as older individuals are more susceptible to neurological and neurodegenerative diseases, including Alzheimer's, Parkinson's, and dementia. This demographic transformation is particularly noticeable in regions like North America, Europe, and parts of Asia, where healthcare systems are increasingly challenged to provide effective diagnostic and neurological services to meet the growing needs of this vulnerable population.
Restraints in the Global Neurology Devices Market
The Global Neurology Devices market faces significant challenges due to the high costs associated with advanced neurovascular devices, which utilize innovative medical technologies. While these expenses may be manageable for developed nations, healthcare facilities in developing regions often contend with constrained budgets, hindering their access to such devices. Additionally, a shortage of specialized training for operating these advanced technologies and interpreting their results poses further obstacles to effective neurological care. Many healthcare providers in underserved locations lack the necessary resources to integrate these innovations, underscoring the urgent requirement for cost-effective solutions and enhanced training initiatives to improve accessibility and patient outcomes.
Market Trends of the Global Neurology Devices Market
The Global Neurology Devices market is witnessing a significant trend driven by advancements in neurostimulation technology. Devices designed to deliver electrical impulses to targeted brain areas or nerves are transforming the treatment landscape for conditions like chronic pain, epilepsy, Parkinson's disease, and dementia. Innovations such as deep brain stimulation (DBS) and spinal cord stimulators (SCS) are gaining traction due to their ability to alleviate symptoms and enhance patients' quality of life while offering minimally invasive alternatives. Increasing demand for neurostimulation devices boasting enhanced precision, connectivity, and improved battery life reflects the growing preference among patients and healthcare professionals for advanced therapeutic solutions.